Your browser doesn't support javascript.
loading
Neuroticism Associates with Cerebral in Vivo Serotonin Transporter Binding Differently in Males and Females.
Tuominen, Lauri; Miettunen, Jouko; Cannon, Dara M; Drevets, Wayne C; Frokjaer, Vibe G; Hirvonen, Jussi; Ichise, Masanori; Jensen, Peter S; Keltikangas-Järvinen, Liisa; Klaver, Jacqueline M; Knudsen, Gitte M; Takano, Akihiro; Suhara, Tetsuya; Hietala, Jarmo.
Afiliación
  • Tuominen L; Turku PET Centre, Turku University Hospital, Turku, Finland; Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Cambridge, MA; Center for Life Course Health Research, University of Oulu, Finland & Medical Research Center (MRC) Oulu, Oulu University Hospital and
  • Miettunen J; Turku PET Centre, Turku University Hospital, Turku, Finland; Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Cambridge, MA; Center for Life Course Health Research, University of Oulu, Finland & Medical Research Center (MRC) Oulu, Oulu University Hospital and
  • Cannon DM; Turku PET Centre, Turku University Hospital, Turku, Finland; Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Cambridge, MA; Center for Life Course Health Research, University of Oulu, Finland & Medical Research Center (MRC) Oulu, Oulu University Hospital and
  • Drevets WC; Turku PET Centre, Turku University Hospital, Turku, Finland; Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Cambridge, MA; Center for Life Course Health Research, University of Oulu, Finland & Medical Research Center (MRC) Oulu, Oulu University Hospital and
  • Frokjaer VG; Turku PET Centre, Turku University Hospital, Turku, Finland; Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Cambridge, MA; Center for Life Course Health Research, University of Oulu, Finland & Medical Research Center (MRC) Oulu, Oulu University Hospital and
  • Hirvonen J; Turku PET Centre, Turku University Hospital, Turku, Finland; Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Cambridge, MA; Center for Life Course Health Research, University of Oulu, Finland & Medical Research Center (MRC) Oulu, Oulu University Hospital and
  • Ichise M; Turku PET Centre, Turku University Hospital, Turku, Finland; Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Cambridge, MA; Center for Life Course Health Research, University of Oulu, Finland & Medical Research Center (MRC) Oulu, Oulu University Hospital and
  • Jensen PS; Turku PET Centre, Turku University Hospital, Turku, Finland; Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Cambridge, MA; Center for Life Course Health Research, University of Oulu, Finland & Medical Research Center (MRC) Oulu, Oulu University Hospital and
  • Keltikangas-Järvinen L; Turku PET Centre, Turku University Hospital, Turku, Finland; Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Cambridge, MA; Center for Life Course Health Research, University of Oulu, Finland & Medical Research Center (MRC) Oulu, Oulu University Hospital and
  • Klaver JM; Turku PET Centre, Turku University Hospital, Turku, Finland; Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Cambridge, MA; Center for Life Course Health Research, University of Oulu, Finland & Medical Research Center (MRC) Oulu, Oulu University Hospital and
  • Knudsen GM; Turku PET Centre, Turku University Hospital, Turku, Finland; Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Cambridge, MA; Center for Life Course Health Research, University of Oulu, Finland & Medical Research Center (MRC) Oulu, Oulu University Hospital and
  • Takano A; Turku PET Centre, Turku University Hospital, Turku, Finland; Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Cambridge, MA; Center for Life Course Health Research, University of Oulu, Finland & Medical Research Center (MRC) Oulu, Oulu University Hospital and
  • Suhara T; Turku PET Centre, Turku University Hospital, Turku, Finland; Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Cambridge, MA; Center for Life Course Health Research, University of Oulu, Finland & Medical Research Center (MRC) Oulu, Oulu University Hospital and
  • Hietala J; Turku PET Centre, Turku University Hospital, Turku, Finland; Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Cambridge, MA; Center for Life Course Health Research, University of Oulu, Finland & Medical Research Center (MRC) Oulu, Oulu University Hospital and
Int J Neuropsychopharmacol ; 20(12): 963-970, 2017 12 01.
Article en En | MEDLINE | ID: mdl-29020405
Background: Neuroticism is a major risk factor for affective disorders. This personality trait has been hypothesized to associate with synaptic availability of the serotonin transporter, which critically controls serotonergic tone in the brain. However, earlier studies linking neuroticism and serotonin transporter have failed to produce converging findings. Because sex affects both the serotonergic system and the risk that neuroticism poses to the individual, sex may modify the association between neuroticism and serotonin transporter, but this question has not been investigated by previous studies. Methods: Here, we combined data from 4 different positron emission tomography imaging centers to address whether neuroticism is related to serotonin transporter binding in vivo. The data set included serotonin transporter binding potential values from the thalamus and striatum and personality scores from 91 healthy males and 56 healthy females. We specifically tested if the association between neuroticism and serotonin transporter is different in females and males. Results: We found that neuroticism and thalamic serotonin transporter binding potentials were associated in both males and females, but with opposite directionality. Higher neuroticism associated with higher serotonin transporter binding potential in males (standardized beta 0.292, P=.008), whereas in females, higher neuroticism associated with lower serotonin transporter binding potential (standardized beta -0.288, P=.014). Conclusions: The finding is in agreement with recent studies showing that the serotonergic system is involved in affective disorders differently in males and females and suggests that contribution of thalamic serotonin transporter to the risk of affective disorders depends on sex.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Corteza Cerebral / Caracteres Sexuales / Proteínas de Transporte de Serotonina en la Membrana Plasmática / Neuroticismo Tipo de estudio: Clinical_trials / Diagnostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Neuropsychopharmacol Asunto de la revista: NEUROLOGIA / PSICOFARMACOLOGIA Año: 2017 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Corteza Cerebral / Caracteres Sexuales / Proteínas de Transporte de Serotonina en la Membrana Plasmática / Neuroticismo Tipo de estudio: Clinical_trials / Diagnostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Neuropsychopharmacol Asunto de la revista: NEUROLOGIA / PSICOFARMACOLOGIA Año: 2017 Tipo del documento: Article